Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
5.57
+0.09 (1.64%)
Nov 21, 2024, 4:00 PM EST - Market closed
Design Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 315 | 148 | 573 | 1,183 | - | - |
| Market Cap Growth | 130.58% | -74.10% | -51.55% | - | - | - |
| Enterprise Value | 59 | -139 | 233 | 793 | - | - |
| Last Close Price | 5.48 | 2.65 | 10.26 | 21.41 | - | - |
| PB Ratio | 1.23 | 0.53 | 1.75 | 3.09 | - | - |
| P/TBV Ratio | 1.21 | 0.53 | 1.75 | 3.09 | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | - | -0.19 |
| Asset Turnover | - | - | - | - | 0.01 | - |
| Quick Ratio | 34.35 | 29.44 | 30.76 | 72.72 | 15.49 | 0.02 |
| Current Ratio | 34.61 | 29.58 | 31.10 | 72.96 | 15.55 | 0.02 |
| Return on Equity (ROE) | -17.78% | -22.10% | -17.85% | -17.08% | -54.48% | - |
| Return on Assets (ROA) | -13.54% | -15.49% | -11.55% | -10.49% | -28.44% | - |
| Return on Capital (ROIC) | -13.99% | -15.98% | -11.79% | -10.67% | -33.49% | - |
| Earnings Yield | -15.18% | -45.06% | -11.05% | -3.00% | - | - |
| FCF Yield | -14.74% | -39.63% | -9.12% | -2.61% | - | - |
| Buyback Yield / Dilution | -0.91% | -0.50% | -21.27% | -190.80% | -2.08% | - |
| Total Shareholder Return | -0.91% | -0.50% | -21.27% | -190.80% | -2.08% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.